ABL Share Price

Open 36.48 Change Price %
High 36.48 1 Day 0.00 0.00
Low 36.48 1 Week -0.55 -1.49
Close 36.48 1 Month -0.61 -1.64
Volume 100 1 Year -3.21 -8.09
52 Week High 43.74
52 Week Low 32.63
ABL Important Levels
Resistance 2 36.48
Resistance 1 36.48
Pivot 36.48
Support 1 36.48
Support 2 36.48
ETR Germany Most Active Stocks
DBK 13.38 0.68%
DBK 13.38 0.68%
DTE 15.02 -0.33%
DTE 15.02 -0.33%
DTE 15.02 -0.33%
DTE 15.02 -0.33%
DTE 15.02 -0.33%
CBK 6.30 0.64%
CBK 6.30 0.64%
EOAN 6.68 -0.30%
ETR Germany Top Gainers Stocks
S9H 0.16 45.45%
5M71 39.00 13.70%
LTEC 22.10 12.47%
SGM 7.96 10.56%
SGM 7.96 10.56%
SGM 7.96 10.56%
SGMR 7.94 9.97%
TNE2 8.86 7.92%
PS4 2.53 7.66%
NK1A 0.90 7.14%
ETR Germany Top Losers Stocks
MPI 0.25 -98.98%
MPI 0.25 -98.98%
APL 2.60 -34.18%
APL 2.60 -34.18%
APL 2.60 -34.18%
AIXB 4.54 -11.84%
D6H 21.60 -8.36%
R3Q 0.11 -8.33%
H2R 5.43 -7.97%
ADV 7.34 -7.67%

Abbott Laboratories (ETR: ABL)

ABL Technical Analysis 3
As on 26th Oct 2016 ABL Share Price closed @ 36.48 and we RECOMMEND Sell for LONG-TERM with Stoploss of 38.62 & Sell for SHORT-TERM with Stoploss of 38.10 we also expect STOCK to react on Following IMPORTANT LEVELS.
ABL Target for October
1st Target up-side 38.18
2nd Target up-side 38.94
3rd Target up-side 39.71
1st Target down-side 36
2nd Target down-side 35.24
3rd Target down-side 34.47
ABL Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.abbott.com
ABL Address
100 Abbott Park Road
Abbott Park, IL 60064
United States
Phone: 847-937-6100
ABL Latest News
Interactive Technical Analysis Chart Abbott Laboratories ( ABL ETR Germany )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Abbott Laboratories
ABL Business Profile
Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome, intrahepatic cholestasis or depressive symptoms, gynecological disorders, dyslipidemia, hypertension, hypothyroidism, pain, fever, and inflammation; and regulates physiological rhythm of the colon, as well as provides hormone replacement therapy and anti-infective and influenza vaccines. The company’s Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; hematology systems and reagents; genomic-based tests; informatics and automation solutions; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company’s Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular diseases. Abbott Laboratories also offers blood glucose and glucose monitoring systems, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians’ offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.